Intellectual Property India Publishes Patent Application for 'Multispecific Molecules For Clearance Of Immunoglobulins In The Treatment Of Autoantibody-Induced Diseases' Filed by Amgen Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517046093 A) filed by Amgen Inc., Thousand Oaks, U.S.A., on May 13, for 'multispecific molecules for clearance of immunoglobulins in the treatment of autoantibody-induced diseases.'

Inventor(s) include Devanaboyina, Venkata Siva Charan; and Li, Peng.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present invention is directed to multispecific molecules that bind immunoglobulin and a recycling target. Binding immunoglobulin and a recycling target results in degradation of immunoglobulin and in certain embodiments recycling of the multispecific molecule. The multispecific molecules of the present invention are thought to be useful in the treatment of autoantibody-induced diseases."

The patent application was internationally filed on Oct. 25, 2023, under International application No.PCT/US2023/077772.

Disclaimer: Curated by HT Syndication.